The company aims to use the power of AI to tackle various diseases and could receive nearly $3bn from its new research collaborations.
Read more: Isomorphic signs drug discovery deals with Eli Lilly and Novartis
https://bit.ly/48MGUEb
Read more: Isomorphic signs drug discovery deals with Eli Lilly and Novartis
https://bit.ly/48MGUEb